Utilize current recommendations and guidelines when managing patients with dyslipidemia |
|
|
|
|
|
|
Consider the application of PCSK9 therapeutics for patients with statin intolerance |
|
|
|
|
|
|
Apply knowledge from clinical trial data to develop individualized treatment plans to maximize patients at LDL-C goals |
|
|
|
|
|
|